Senior Director, Clinical Science, Alzheimer's Disease

About this role

At Cogstate, we’re advancing the science of brain health - making it faster, easier, and more accurate to assess cognition across clinical trials, healthcare settings, and everyday life.

Our digital cognitive assessments are trusted by researchers, clinicians, and pharmaceutical partners around the world, helping to drive breakthroughs in neuroscience and improve outcomes for people living with neurological conditions. Founded on decades of cognitive science and backed by rigorous validation, Cogstate’s assessments are used in more than 150 countries and over 2,000 clinical trials.

Our global team of experts - spanning psychology, data science, operations, and technology - works together to solve complex challenges in brain health assessment, always with a patient-first mindset. Whether we’re supporting a multinational Alzheimer’s trial or developing tools to bring cognitive testing into routine care, our work is meaningful, collaborative, and constantly evolving.

At Cogstate, we’re not just imagining the future of brain health - we’re building it.

That’s why we’re seeking a Senior Director, Clinical Science, Alzheimer Disease accountable for directing, planning, innovating, and overseeing the development and delivery of products and services related to endpoint management and quality assurance in global clinical trials of AD and other related neurogenerative disease therapeutic areas. They are actively engaged in supporting commercial business development consultative sales process and in guiding scientific operational delivery of data quality management programs for awarded contracts.

The Senior Director supports product and service development including collaborating with external expert clinician consultants, as well as guiding and contributing to the publications/conference presentation plan related to Cogstate expertise in AD.

Key Responsibilities

•